EBS vs PEG · rev $1.04B vs P/E 18, rev $10.29B
Emergent Biosolutions Inc (EBS) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
EBS currently screens at market cap $416.4M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the EBS and PEG stock pages for the full models.
Not investment advice.